Pulmicort
Budesonide 200mcg (Brand) Astra |
1 | 200 doses inhalar |
74 € | Buy Now |
Singulair

Foradil

Foranoterol fumerate 12mcg/cap (Brand) Novartis |
60 | Caps | Inhalation-caps | 78 € | Buy Now |
Serevent
Seretide
Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and COPD.
Formoterol has an extended duration of action (up to 12 h)
compared to short-acting β2 agonists such as salbutamol (albuterol),
which are effective for 4 h to 6 h. LABAs such as formoterol are used as “symptom controllers” to supplement
prophylactic corticosteroid therapy.
A “reliever” short-acting β2 agonist (e.g., salbutamol) is still required since LABAs are not recommended for the
treatment of acute asthma
n November 2005, the US FDA released a health advisory alerting the public to findings that show the use of long-
acting β2 agonists could lead to a worsening of wheezing symptoms in some patients.[2]
At the current time, available long-acting β2 agonists include salmeterol, formoterol, bambuterol,
and sustained-release oral salbutamol.
Combinations of inhaled steroids and long-acting bronchodilators are becoming more widespread – combination
preparations include fluticasone/salmeterol and budesonide/formoterol